Orion Oyj ORNBV

HEL: ORNBV | ISIN: FI0009014377   23/12/2024
42,44 EUR (-0,79%)
(-0,79%)   23/12/2024

19 december 2024 · CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel · Persbericht

19 december 2024 · Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel · Persbericht

18 december 2024 · Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics · Persbericht

12 december 2024 · Penalty payment to a member of Orion’s Board of Directors for delay in notifying managers’ transaction · Persbericht

27 november 2024 · 142,701 Orion Corporation A shares converted into B shares · Persbericht

22 november 2024 · Orion Research Foundation grants EUR 1,109,000 for research in 2025 · Persbericht

19 november 2024 · Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies · Persbericht

1 november 2024 · Orion Corporation: Managers’ transactions – Henrik Stenqvist · Persbericht

29 oktober 2024 · Orion Group Interim Report January–September 2024 · Persbericht

24 oktober 2024 · Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule · Persbericht

15 oktober 2024 · Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024 · Persbericht

14 oktober 2024 · Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU · Persbericht

30 september 2024 · Orion’s near-term climate targets approved by the Science Based Targets initiative · Persbericht

26 september 2024 · Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster · Persbericht

20 september 2024 · 213,285 Orion Corporation A shares converted into B shares · Persbericht

11 september 2024 · Inside information: Orion upgrades full-year outlook for 2024 · Persbericht

22 augustus 2024 · Orion Corporation: Managers’ transactions – Satu Ahomäki · Persbericht

21 augustus 2024 · Orion Corporation: Managers’ transactions – Niclas Lindstedt · Persbericht

20 augustus 2024 · Orion Corporation: Managers’ transactions – Liisa Hurme · Persbericht

15 augustus 2024 · Orion Corporation: Managers’ transactions – Hao Pan · Persbericht

Mijn selecties